Skip to content

Research use only Research use only — all products are sold as laboratory reference materials. Not for human or veterinary consumption.

Read the terms
Sexual Wellness

PT-141

The passion peptide — a popular choice for libido and sexual wellness.

10mg €10.00

Supplied for laboratory research use only. Not for human or veterinary consumption.

PT-141

What is it?

PT-141 (bremelanotide) is a well-known peptide in the sexual-wellness world, popular with people who want to support libido and intimacy. It has a strong, loyal following because it addresses something many products simply don't.

Why people choose it

  • A leading name in sexual wellness
  • Popular for supporting libido
  • A discreet, sought-after option
  • A confident addition to a wellness routine

What is it used for?

  • Libido and desire
  • Sexual wellness and confidence

How it works

Unlike options that work only on blood flow, PT-141 is discussed in relation to the brain's desire pathways. That different angle is a big part of its appeal.

Good to know

  • A discreet favourite in the sexual-wellness space.
  • Sometimes considered alongside Melanotan (MT2).
  • Popular for confidence and intimacy.

Available options

10mg €10.00

Every option can be ordered directly through the cart above.

Research use only — not for human or veterinary consumption.

Dosage protocol

Reconstitution maths, titration steps and syringe draw volumes as published by peptidedosages.com.

Reference information only — not medical advice and not a prescription. Speak to a qualified professional before using any peptide.

Route
Subcutaneous injection
Cycle length
8–16 weeks

Mixing (reconstitution)

Vial Add BAC water Concentration 1 unit (0.01 ml)
10 mg 3 mL 3.33 mg/mL 33.3 mcg

Dosing schedule

Frequency: Once daily
Phase Dose Units Volume
Weeks 1–8 500 mcg 15 units 0.15 mL
Weeks 9–12 1,000 mcg 30 units 0.30 mL
Weeks 13–16 1,500 mcg 45 units 0.45 mL

Storage

  • Powder (unmixed): −20 °C
  • After mixing: 2–8 °C
  • Use within: days
  • Avoid freeze–thaw cycles

Technique

  • Clean the vial stopper and the skin with an alcohol swab and let both air-dry.
  • Pinch a skinfold and insert the needle at 45–90° into the subcutaneous tissue.
  • Do not aspirate for subcutaneous injections — inject slowly and steadily.
  • Wait 5–10 seconds before withdrawing, then apply gentle pressure. Do not rub the site.
  • Rotate sites systematically — abdomen (at least 5 cm from the navel), thighs and upper arms — to avoid lipohypertrophy.
  • Use a new sterile 28–31 G insulin syringe every time and dispose of it in a sharps container.

Reported side effects

  • Nausea (around 40%)
  • Flushing
  • Headache
  • Injection-site reactions
  • Transient rises in blood pressure
  • Skin darkening (hyperpigmentation)

Safety & evidence

  • FDA-approved in 2019 for hypoactive sexual desire disorder in premenopausal women.
  • This schedule uses consistent daily dosing rather than the on-demand FDA dosing.
  • Not recommended for anyone with uncontrolled hypertension or cardiovascular disease.
  • The subcutaneous route gives roughly 100% bioavailability.

Figures transcribed from peptidedosages.com: /single-peptide-dosages/pt-141-10-mg-vial-dosage-protocol/

Order or ask a question

Add your size to the cart, or email us if you have a question first.